| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-08 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |